Transcend Capital Advisors, LLC Bristol Myers Squibb CO Transaction History
Transcend Capital Advisors, LLC
- $1.42 Billion
- Q3 2025
A detailed history of Transcend Capital Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Transcend Capital Advisors, LLC holds 59,529 shares of BMY stock, worth $2.79 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
59,529
Previous 57,576
3.39%
Holding current value
$2.79 Million
Previous $2.67 Million
0.71%
% of portfolio
0.19%
Previous 0.21%
Shares
24 transactions
Others Institutions Holding BMY
# of Institutions
2,684Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...